Stay tuned for an announcement about the next Hope & Health Now Webinar scheduled for October
Links to the webinar now available to view. Tune in to hear experts share about COVID-19 vaccine facts: vaccine development, safety regulation, respiratory viruses and your legal rights.
The published paper finds evidence from the literature of in large increase in prevalence and suggests that it should be a matter of urgent public concern.
California Autism Prevalence Trends from 1931 to 2014 and Comparison to National ASD Data from IDEA and ADDM
The prevalence of autism in the CDDS dataset, the longest of the three data records, increased from 0.001% in the cohort born in 1931 to 1.2% among 5 year-olds born in 2012. This increase began around ~ 1940 at a rate that has gradually accelerated over time, including notable change points around birth years 1980, 1990 and, most recently, 2007.
Using literature AD data from long-term (approximately 10-year) studies, we determined cumulative incidence of AD for each cohort within each study.
This review summarizes results that correlate the timing of changes in incidence with environmental changes. Autism could result from more than one cause, with different manifestations in different individuals that share common symptoms.
This open letter was written to US legislators by SCPI Founder and Scientist, Dr. Theresa Deisher, regarding fetal DNA contaminants in the Measles-Mumps-Rubella vaccine. You may share with your legislators and others who should have this information.
Insertional Mutagenesis and Autoimmunity Induced Disease Caused by Human Fetal and Retroviral Residual Toxins in Vaccines
This published paper aims to inform vaccine manufacturing and cell substrate residual contaminant levels, insertional mutagenesis and autoimmunity and the relationship these pathological processes to current childhood disease epidemics including autistic disorder, leukemia, lymphoma, intellectual disability, schizophrenia and bipolar disorder.
Epidemiologic and Molecular Relationship Between Vaccine Manufacture and Autism Spectrum Disorder Prevalence
Changepoint analysis of autism disorder demonstrates a temporal correlation with events associated with human DNA residuals in vaccines. The levels of residual DNA are well over FDA-recommended limits.